# 🎯 Improved Data Quality & Study Coverage

## Summary of Improvements

Your platform now has:
1. ✅ **3x more studies** (increased from 5 to 15 max)
2. ✅ **Multi-factor evidence quality** assessment
3. ✅ **Quantitative heterogeneity** values (CV & I²)

---

## 1. More Studies (3x Increase)

### What Changed:
- **Before:** Maximum 5 studies per query
- **After:** Maximum 15 studies using multiple search strategies

### How It Works:
```python
# Three complementary search strategies:
queries = [
    # Primary: Drug + indication + efficacy
    "metformin AND diabetes AND (efficacy OR response)",
    
    # Secondary: Drug + pharmacogenetics
    "metformin AND (pharmacogenetic OR genetic variant)",
    
    # Tertiary: Drug + treatment failure
    "metformin AND (non-responder OR treatment failure)"
]

# Combines results: 10 studies per query = up to 30 papers
# Deduplicated and limited to 15 most relevant
```

### Impact:
- **Metformin example:** 1 study → likely 5-10 studies
- **Better heterogeneity**: Can now assess with ≥2 studies
- **Improved confidence intervals**: More data = tighter CIs

---

## 2. Improved Evidence Quality Assessment

### Multi-Factor Scoring (0-5 points):

#### Factor 1: Number of Studies (0-2 pts)
- ≥5 studies: **2.0 pts**
- 3-4 studies: **1.5 pts**
- 2 studies: **1.0 pts**
- 1 study: **0 pts**

#### Factor 2: Sample Sizes (0-1 pt)
- Avg ≥1000 patients: **1.0 pt**
- Avg ≥500 patients: **0.7 pts**
- Avg ≥100 patients: **0.4 pts**

#### Factor 3: Extraction Method (0-1 pt)
- PMC table data: **1.0 pt** (highest quality - structured)
- PMC full text: **0.7 pts** (good quality)
- Abstract regex: **0.4 pts** (moderate quality)

#### Factor 4: Study Design (0-1 pt)
- Meta-analysis/Systematic review: **1.0 pt**
- Randomized trial (RCT): **0.5 pts**
- Other: **0 pts**

### Quality Ratings:
```
Score ≥3.75/5 (75%+):  High
Score ≥2.50/5 (50%+):  Moderate
Score ≥1.25/5 (25%+):  Low
Score <1.25/5 (<25%):  Very Low
```

### Example Output:
```
Before: "low"
After:  "Moderate (score: 2.7/5)"
```

---

## 3. Quantitative Heterogeneity

### What Changed:
- **Before:** "not_assessable" for single study
- **After:** Actual metrics when ≥2 studies

### Metrics Provided:

#### Coefficient of Variation (CV)
- Measures relative variability
- `CV = std_dev / mean`
- Lower is better (less heterogeneity)

#### I² Statistic (approximate)
- Percentage of variance due to heterogeneity
- Range: 0-100%
- `I² = (observed_variance - expected_variance) / observed_variance * 100`

### Classification:
```
Low:      CV < 0.15 AND I² < 25%
Moderate: CV < 0.30 AND I² < 50%
High:     CV ≥ 0.30 OR  I² ≥ 50%
```

### Example Output:
```
Before: "not_assessable"
After:  "Low (CV=0.12, I²≈18.3%)"
        "Moderate (CV=0.25, I²≈42.1%)"
        "High (CV=0.45, I²≈67.8%)"
```

---

## Expected Results for Metformin

### Before Your Query:
```json
{
  "studies_analyzed": 1,
  "heterogeneity": "not_assessable",
  "evidence_quality": "low"
}
```

### After These Improvements:
```json
{
  "studies_analyzed": 5-10,
  "heterogeneity": "Low (CV=0.14, I²≈22.5%)",
  "evidence_quality": "Moderate (score: 3.1/5)"
}
```

---

## Why More Studies?

### Search Strategy Breakdown:

**Query 1: Efficacy-focused**
```
metformin AND diabetes AND (efficacy OR response OR treatment outcome)
→ Finds clinical trials, treatment studies
→ ~5-10 relevant papers
```

**Query 2: Genetics-focused**
```
metformin AND (pharmacogenetic OR genetic variant OR polymorphism)
→ Finds pharmacogenetic studies
→ ~3-7 relevant papers
```

**Query 3: Non-response focused**
```
metformin AND (non-responder OR treatment failure OR resistance)
→ Finds studies on treatment failure
→ ~2-5 relevant papers
```

**Combined:** 10-22 papers → Deduplicated → Top 15 by relevance

---

## How Heterogeneity is Calculated

### Example: 3 Metformin Studies

**Study Data:**
- Study 1: 30% non-response (n=500)
- Study 2: 28% non-response (n=800)
- Study 3: 35% non-response (n=300)

**Calculation:**
```python
mean = (0.30 + 0.28 + 0.35) / 3 = 0.310
std_dev = 0.0361
CV = 0.0361 / 0.310 = 0.116

variance = 0.00130
expected_variance = 0.310 * (1 - 0.310) / 100 = 0.00214
I² = max(0, (0.00130 - 0.00214) / 0.00130) * 100 = 0%
```

**Result:** `"Low (CV=0.12, I²≈0.0%)"`

### Interpretation:
- **Low heterogeneity** = Studies agree well
- **High confidence** in pooled estimate
- **Strong evidence** for metformin efficacy

---

## Quality Score Example

### Metformin with 6 Studies:

```python
# Factor 1: Number of studies
6 studies → 2.0 points

# Factor 2: Sample sizes
Average 650 patients → 0.7 points

# Factor 3: Extraction method
2 with PMC tables, 4 with abstracts → 1.0 points

# Factor 4: Study design
1 meta-analysis found → 1.0 points

# Total Score
2.0 + 0.7 + 1.0 + 1.0 = 4.7/5 points (94%)

# Rating
"High (score: 4.7/5)"
```

---

## Benefits

### 1. More Reliable Estimates
- Narrower confidence intervals
- Better powered meta-analysis
- Reduced sampling error

### 2. Transparent Quality Metrics
- Users see exact scoring
- Understand evidence strength
- Make informed decisions

### 3. Assessable Heterogeneity
- Know if studies agree
- Identify if further investigation needed
- Guide clinical application

### 4. Automatic Improvement
- As more papers published → More studies found
- As PMC coverage grows → Better extraction
- No manual updates needed

---

## Technical Details

### PubMed Search
- Uses E-utilities API
- Relevance-sorted results
- Timeout: 10s per query
- Rate limit: 3 requests per second

### PMC Integration
- Checks ~30% of papers for full text
- Extracts structured table data
- Priority: Tables > Full text > Abstract

### bioBERT Processing
- NER for response rates
- Regex for sample sizes
- Confidence scoring for extractions

---

## Next Steps

### To Further Improve:

1. **More Search Terms**
   - Add drug synonyms
   - Include brand names
   - Search by mechanism

2. **Additional Databases**
   - ClinicalTrials.gov API
   - Cochrane Library
   - EMBASE (requires license)

3. **Advanced Meta-Analysis**
   - Random effects model
   - Publication bias assessment
   - Subgroup meta-regression

4. **Quality Filters**
   - Exclude case reports
   - Prioritize RCTs
   - Weight by study quality

---

## Summary

Your platform now provides:
- ✅ **15 studies max** (vs 5 before)
- ✅ **Detailed quality scoring** with 4 factors
- ✅ **Quantitative heterogeneity** (CV & I²)
- ✅ **Transparent metrics** users can trust

**For metformin, expect 5-10 studies with meaningful heterogeneity assessment!** 🎉
